CD36 serves as a signaling receptor and free fatty acid (FFA) transporter in dyslipidemia: the role of dapagliflozin and alirocumab in downregulating atherogenic dyslipidemia via FFA uptake inhibition—experimental study

Jui‐Ning Yeh(First Affiliated Hospital of Jinan University), Jun Guo(Jinan University), Pei‐Lin Shao, Chi‐Ruei Huang(Chang Gung University), Yi-Ling Chen(Kaohsiung Chang Gung Memorial Hospital), Xianwu Lan(First Affiliated Hospital of Jinan University), Hon‐Kan Yip(Chang Gung University of Science and Technology)
International Journal of Surgery
September 23, 2025
Cited by 3


Related Papers